These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2166634)

  • 1. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
    Stratton CW; Weeks LS
    Diagn Microbiol Infect Dis; 1990; 13(3):245-52. PubMed ID: 2166634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
    Van der Auwera P
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1783-90. PubMed ID: 2556079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro activity of daptomycin, vancomycin and fluoroquinolones in broth and serum against Staphylococcus epidermidis as determined by time-kill kinetics.
    Lentino JR; Strodthman R
    Chemotherapy; 1989; 35(3):168-73. PubMed ID: 2548817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
    DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
    Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
    Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
    Coudron PE; Johnston JL; Archer GL
    J Antimicrob Chemother; 1987 Oct; 20(4):505-11. PubMed ID: 2824426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of daptomycin against 297 staphylococcal isolates.
    Digranes A; Benonisen E
    Chemotherapy; 1990; 36(2):136-40. PubMed ID: 2155761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity of daptomycin against vancomycin-resistant Enterococcus faecium in an in vitro pharmacokinetic model.
    Bingen E; Doit C; Lambert-Zechovsky N; Tod M; Petitjean O; Bourgeois F; Mariani-Kurkdjian P
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1062-5. PubMed ID: 1666362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.
    Hanberger H; Nilsson LE; Maller R; Isaksson B
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1710-6. PubMed ID: 1659305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
    Stratton CW; Liu C; Weeks LS
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1210-5. PubMed ID: 2820300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin.
    Bailey EM; Rybak MJ; Kaatz GW
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1089-92. PubMed ID: 1834010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin.
    Lamp KC; Rybak MJ; Bailey EM; Kaatz GW
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2709-14. PubMed ID: 1336344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model.
    Blenkharn JI; Darrell JH
    Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):734-7. PubMed ID: 2550236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of gram-positive cocci to paldimycin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    Antimicrob Agents Chemother; 1987 Jan; 31(1):104-7. PubMed ID: 3105438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Shonekan D; Mildvan D; Handwerger S
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of protein binding under controlled conditions on the bactericidal activity of daptomycin in an in vitro pharmacodynamic model.
    Cha R; Rybak MJ
    J Antimicrob Chemother; 2004 Jul; 54(1):259-62. PubMed ID: 15150172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.